Prima appoints new CEO to reflect European focus
11 July, 2014 by Dylan Bushell-EmblingPrima BioMed (ASX:PRR), having centralised its clinical and manufacturing operations in Europe, has promoted its head of European operations to CEO.
Rhinomed partners to promote Turbine device
10 July, 2014 by Dylan Bushell-EmblingRhinomed (ASX:RNO) has announced a partnership to promote its fitness breathing device Turbine at Fitness First gyms and revealed that sales of the device hit $201K during the June quarter.
NSW medical devices commercial training program open for early-career postgraduates
10 July, 2014Expressions of interest are invited for a new training program that will arm early-career postgraduate researchers involved in medical technology and product-related research with the necessary entrepreneurial skills to successfully commercialise a medical technology.
Antisense wins Canadian patent for IGF-I modulator
09 July, 2014 by Dylan Bushell-EmblingAntisense Therapeutics has picked up a Canadian patent covering ATL1103 - a potential treatment for growth disorders including acromegaly - and has dosed 24 patients in a phase II trial.
QRxPharma chair, three directors step down
09 July, 2014 by Dylan Bushell-EmblingFour QRxPharma (ASX:QRX) board members, including chairman Dr Peter Farrell, have resigned hours before a board-spill vote called by a group of unhappy shareholders.
AusBiotech July journal features 'manufacturing, money and medtech'
08 July, 2014The latest edition of AusBiotech's journal, Australasian Biotechnology (July 2014, Volume 24, Number 2), is out now.
NeuClone signs biosimilar deal with Serum Institute
07 July, 2014 by Dylan Bushell-EmblingSydney's NeuClone has entered a global partnership with The Serum Institute of India to produce a portfolio of 10 biosimilar monoclonal antibody drugs.
Analytica recruits clinicians for PeriCoach rollout
03 July, 2014 by Dylan Bushell-EmblingAnalytica (ASX:ALT) has recruited the first group of Australian clinician referral partners for its controlled launch of urinary incontinence device therapy PeriCoach.
AusBiotech wins grant to develop Australian medtech directory for China
03 July, 2014AusBiotech has been awarded a grant to develop a bilingual directory of Australian medical technology (devices and diagnostics) companies in Chinese/English to support business partnering and facilitate trade with China.
Support for small to medium businesses
03 July, 2014The Entrepreneurs' Infrastructure Programme is accepting applications for Business Evaluations and Business Growth Grants.
Simavita doubles Aust sales, books first US revenues
03 July, 2014 by Dylan Bushell-EmblingSimavita (ASX:SVA) revealed it had doubled Australian monthly revenues for its incontinence management products and its distribution partner has commenced sales in the US.
GI Dynamics warns on Q2 revenue
02 July, 2014 by Dylan Bushell-EmblingGI Dynamics (ASX:GID) has estimated it will report a slight sequential decline in Q2 revenue, and announced the resignation of chief commercial officer Mark C Twyman.
Australia ranks fourth on biotech scorecard
01 July, 2014 by Lauren DavisScientific American Worldview has released its latest scorecard, which measures biotechnology innovation around the world. Australia ranked extremely well on the scorecard, jumping from seventh position last year to fourth this year.
Iluvien close to approval in 10 more EU markets
01 July, 2014 by Dylan Bushell-EmblingpSivida (ASX:PVA) partner Alimera is on track to securing approval for diabetic macular oedema treatment Iluvien in 10 more European markets, taking the total up to 17.
Australian Export Awards 2014 now open
01 July, 2014The Australian Export Awards, run by Austrade and the Australia Chamber of Commerce and Industry, has launched its 2014 program and is looking for Australia's business success stories.
